Format for printing Reuse/Reprint
	The Year in Review Introduction The Top Investing Stories The Winners The Losers Our Greatest Hits What We've Learned Investing Opportunities in 2001 The Worst of "Investing 2000"

Now that we've reviewed the eventful year just past, let's think about the future, which is what investors are supposed to spend most of their time doing anyway. Enough wringing of hands and rending of garments over one tough year! It's time to roll up the sleeves and get busy looking for where the next opportunities may be found. In recent days, our writers and analysts have been discussing several different industries, looking for just that: opportunities. Below are links to the results of those discussions, which we've published on our site in the last several weeks.

Software
What are some of the factors investors should look for in the software business next year and beyond? In this discussion transcript, four Fools talk about the outlook for the video game, security, Web-testing, and storage sectors as they try to help market watchers identify the companies that will be tomorrow's leaders.

Optical Components
The optical components industry has attracted plenty of attention due to its rapid growth, but what do investors need to know before exploring investment opportunities in this sector? Three Fools discuss the industry and where it sits in the overall fiber optic equipment value chain.

Biotech
Do biotechnology stocks represent opportunities or pitfalls? Four Fools sat down to share analyses. Their verdict: It's a sector for investors able to act like venture capitalists and take huge risks. Above all, you should know your risk tolerance, have an investing plan, and learn all you can first -- before investing.

Pharmaceuticals
If development stage biotechnology companies are too risky for your investing style, what about established biotech drug makers and big pharmaceutical companies? Four Fool writers share their thoughts on these sectors. They agree that drug makers with products on the market are far less risky than development stage biotechnology companies, but disagree whether as a group they are currently overvalued. It all depends on how many and what quality drugs a company has in its development pipeline.

Retail
From furniture to fashions, the retail industry experienced quite a year in 2000. While online retailers generally were clobbered, there were some surprising successes, such as several footwear companies. Four Fools sit down to discuss the retail industry, both online and off, and how investors can evaluate companies in this sector.

Back to Introduction »